Hospital Outpatient Drug Reimbursement Rates Drive Billions in Excess Healthcare Spending

Research from the Employee Benefit Research Institute indicates that standardizing drug reimbursement rates between hospital outpatient departments and physician offices could reduce national healthcare spending by $12.7 billion annually. The analysis found that hospital outpatient departments received substantially higher reimbursement for 93 physician-administered drugs, with median price differentials of 64% and average differentials of 102%. Implementing site-neutral payment policies could address this significant cost disparity.

The research examined commercial insurance claims across a two-year period, focusing on medications administered to patients in outpatient settings rather than in hospitals or clinics. Hospital outpatient departments handled the majority of these drug administrations—nearly 60% of cases—despite charging significantly more per unit than physician offices for identical medications. The price gap was substantial enough that when multiplied across millions of patients nationally, it totals approximately $100 annually per covered individual.

The disparity raises questions about payment structure efficiency within the healthcare system. While some treatments may require hospital infrastructure, the analysis suggests that many could be delivered in lower-cost settings without compromising care quality. The researchers emphasized that savings would primarily benefit insurers and employers rather than patients, since most individuals have already met their annual out-of-pocket obligations by the time they receive these specialty drugs.